Medistep Healthcare FY26 net profit rises 44% to ₹598.30 lakh

Medistep Healthcare reported a 44.4% increase in net profit to ₹598.30 lakh for the financial year ended March 31, 2026, driven by a 42.6% rise in revenue from operations to ₹7,083.10 lakh. The board approved the standalone audited financial results at its meeting held on May 30, 2026. The statutory auditors issued an unmodified opinion on the results for the year ended March 31, 2026.

Revenue from operations for the year ended March 31, 2026, stood at ₹7,083.10 lakh, compared to ₹4,965.48 lakh in the previous year. Total income for the period rose to ₹7,085.36 lakh from ₹4,965.86 lakh in FY25. Total expenses increased to ₹6,285.83 lakh from ₹4,412.09 lakh in the corresponding period of the previous year.

Financial Performance

The company’s profit before tax for FY26 was ₹799.53 lakh, up from ₹553.77 lakh in the previous year. Following a tax expense of ₹201.23 lakh, the net profit for the year was recorded at ₹598.30 lakh. Earnings per share (EPS) for the year increased to ₹4.68 from ₹4.01 in the prior year.

Metric	FY26 (₹ in Lakhs)	FY25 (₹ in Lakhs)
Revenue from operations	7,083.10	4,965.48
Total income	7,085.36	4,965.86
Total expenses	6,285.83	4,412.09
Profit before tax	799.53	553.77
Net profit	598.30	414.40
Earnings per share (₹)	4.68	4.01

IPO Proceeds Utilization

The company issued 37,44,000 equity shares of ₹10 each at a premium of ₹33 each via a public issue, listing on the EMERGE Platform of the National Stock Exchange of India Limited on August 18, 2025. As of March 31, 2026, the company had utilized ₹1,559.17 lakh of the total IPO proceeds of ₹1,609.92 lakh.

Object of the Issue	Amount Allotted (₹ in Lakhs)	Amount Utilized (₹ in Lakhs)
Working Capital Requirement	1,234.17	1,234.17
General corporate purpose	164.01	164.01
Public issue related expenses	160.99	160.99
Capital Expenditure Requirement	50.75	-
Total	1,609.92	1,559.17

Assets and Liabilities

The total assets of the company as of March 31, 2026, stood at ₹5,029.71 lakh, a significant increase from ₹2,300.08 lakh in the previous year. Shareholders' funds rose to ₹3,782.46 lakh from ₹1,735.22 lakh, driven by an increase in share capital and reserves. Current assets, including inventories and trade receivables, totaled ₹5,015.97 lakh, while current liabilities amounted to ₹1,244.79 lakh.

1 Day	5 Days	1 Month	6 Months	1 Year	5 Years
0.0%	-1.58%	-14.61%	-25.35%	-62.86%	-62.86%

Medistep Healthcare Limited has communicated to the National Stock Exchange of India Ltd. that its promoters have not encumbered any shares held by them during the financial year ended March 31, 2026. This disclosure was submitted to the exchange on April 2, 2026, in accordance with regulatory requirements.

Declaration Details

The declaration was filed under Regulation 31(4) of the SEBI (Substantial Acquisition of Shares and Takeover) Regulations, 2011. This regulation requires promoters to confirm whether they have created any encumbrance, directly or indirectly, on their shareholding during the relevant financial year.

Particulars	Details
Regulation	Regulation 31(4) of SEBI (SAST) Regulations, 2011
Financial Year	Year ended March 31, 2026
Encumbrance Status	No encumbrance made directly or indirectly
Declaration Date	April 2, 2026

Promoter Confirmation

The confirmation was provided on behalf of all promoters of the company. Girdharilal Prajapat, a Promoter of Medistep Healthcare Limited , signed the declaration. The document explicitly states that no shares held by the promoters were subject to any encumbrance during the specified period. The company has requested the exchange to place this information on record.